Ethnicity and age disparities in Ewing sarcoma outcome

Fetal and Pediatric Pathology

Volumn 32, Issue 4, 2013, Pages 246-252

  Koohbanani, Bianca ^a   Han, Gang ^b   Reed, Damon ^b   Zhao, Qing ^c   Yi, Ding ^d   Henderson Jackson, Evita ^c   Bui, Marilyn M ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Department of Biostatistics Core ^*  (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Ewing sarcoma (ES); Ewing sarcoma family of tumors (ESFT); Prognostic factor; Racial disparity

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHILD; CONTROLLED STUDY; ETHNIC DIFFERENCE; EWING SARCOMA; FEMALE; FOLLOW UP; HISPANIC; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEWBORN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, EWING; YOUNG ADULT;

EID: 84879401113     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.3109/15513815.2012.721480     Document Type: Article

References (29)

1. Fletcher C, Unni KK,Mertens F.WorldHealth Organization classification of tumours: Pathology and genetics of tumours of soft tissue and bone. Lyons, France: IARC Press; 2002
2. Pinto A, Dickman P, ParhamD. Pathobiologicmarkers of the ewing sarcoma family of tumors: State of the art and prediction of behaviour. Sarcoma 2011:856190, 2011. doi: 10.1155/2011/856190
3. Jawad MU, Cheung MC, Min ES, et al. Ewing sarcoma demonstrates racial disparities in incidencerelated and sex-related differences in outcome: An analysis of 1631 cases from the SEER database, 1973-2005. Cancer 115(15):3526-3536, 2009
4. Lee J,Hoang BH, Ziogas A, et al. Analysis of prognostic factors in Ewing sarcoma using a populationbased cancer registry. Cancer 116(8):1964-1973, 2010
5. De Angulo G, Hernandez M, Morales-Arias J, et al. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma. J Pediat Hematol Oncol 29(1):48-52, 2007
6. Worch J,Matthay KK, Neuhaus J, et al. Ethnic and racial differences in patients with Ewing sarcoma. Cancer 116(4):983-988, 2010
7. Fraumeni JF, Jr., Glass AG. Rarity of Ewing's sarcoma among U.S. Negro children. Lancet 1(7642):366-367, 1970
8. Li FP, Tu JT, Liu FS, et al. Rarity of Ewing's sarcoma in China. Lancet 1(8180):1255, 1980
9. Parkin DM, Stiller CA, Nectoux J. International variations in the incidence of childhood bone tumours. Int J Cancer 53(3):371-376, 1993
10. Martin RC, 2nd, Brennan MF. Adult soft tissue Ewing sarcoma or primitive neuroectodermal tumors: Predictors of survival? Arch Surg 138(3):281-285, 2003
11. Sinkovics JG, Plager C, Ayala AG, et al. Ewing sarcoma: Its course and treatment in 50 adult patients. Oncology 37(2):114-119, 1980
12. Bacci G, Forni C, Longhi A, et al. Long-Term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies: 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 40(1):73-83, 2004
13. Verrill MW, Judson IR, Harmer CL, et al. Ewing's sarcoma and primitive neuroectodermal tumor in adults: Are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children? J Clin Oncol 15(7):2611-2621, 1997
14. Yamada K, SugiuraH, Takahashi M. Single center experience of treatment of Ewing's family of tumors in Japan. J Orthop sci 11(1):34-41, 2006
15. Bacci G, Balladelli A, Forni C, et al. Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: Report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years. Cancer 109:780-786, 2007
16. Bhatia S. Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia. Curr Opin Pediatr 16(1):9-14, 2004
17. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100(6):1957-1964, 2002
18. Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290(15):2008-2014, 2003
19. Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer 113(9):2575-2596, 2008
20. Castellino SM,Casillas J,HudsonMM,et al.Minority adult survivors of childhood cancer: A comparison of long-Termoutcomes, health care utilization, and health-related behaviors fromthe childhood cancer survivor study. J Clinic oncol 23(27):6499-6507, 2005
21. Oberlin O, Deley MC, Bui BN, et al. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: The third study of the French Society of Paediatric Oncology (EW88 study). Brit J cancer 85(11):1646-1654, 2001
22. Burroughs V, Maxey R, Levy R. Racial and ethnic differences in response to medicines: Towards individualized pharmaceutical treatment. J NatlMed Assoc 94(10):1-26, 2002
23. Urban T. Race, ethnicity, ancestry, and pharmacogenetics.MS JMedicine 77:133-139, 2010
24. Jones D. How personalized medicine became genetic, and racial: Werner kalow and the formations of pharmacogenetics. J HistMed All Sci 2011
25. Esiashvili N, Goodman M, Marcus RB, Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance epidemiology and end results data. J PediatHematolOncol 30(6):425-430, 2008
26. PaulussenM, Ahrens S,Dunst J, et al. Localized Ewing tumor of bone: Final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19(6):1818-1829, 2001
27. Sauer R, JurgensH, Burgers JM, et al. Prognostic factors in the treatment of Ewing's sarcoma.TheEwing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81. Radiother Oncol 10(2):101-110, 1987
28. Zang J, Guo W, Yang RL,et al. [Ewing's sarcoma of bone:treatment results and prognostic factors]. Zhonghua wai ke za zhi [Chinese J Surg] 48(12):896-899, 2010
29. Bacci G, Ferrari S, Longhi A, et al. Prognostic significance of serumLDHin Ewing's sarcoma of bone. Oncol Rep 6(4):807-811, 1999